$DRMA

$0.87 +$0.12 (15.85%) Close

$DRMA Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 4.0M shares outstanding

Who owns DRMA?

By type of holder

Institutions 2.7% Insiders 73.2% Everyone else 24.1%

Concentration Top 10 holders own 32.7%

Proehl Gerald T 17.3% · Kyri K. Van Hoose 9.6%

Institutional ownership

2.7%

0.0 pts vs last qtr

Institutional holders

+5 vs last qtr

Net shares bought

+32

by institutions in Q2 2026

New / sold out

6 / 1

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

State Street Corp NEW +18.7K
XTX Topco Ltd NEW +14.8K

Biggest sellers in Q2 2026

Geode Capital Management, LLC −28.1K
UBS Group AG −18.8K

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Dermata Therapeutics Inc in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2023–FY2025

+969.1%

+226.97% a year

Each share's claim on the business

−90.6%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $1.32M

over 3 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years0% 3–5 years19% 1–3 years0% Under 1 year81%

Quarterly turnover

44.1%

of institutional shares changed hands

Top 10 managers, median time held

1 quarter

Super Investors

Investment managers reporting DRMA on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
GC Geode Capital Management, LLC	20.2K	0.50%	−28.1K (−58.2%)	Q1 '26	0.0%
Shares held by quarter Peak holding48.3K (Q1'26) Change over 8 quarters+20.2K Share of the company0.500% Geode Capital Management, LLC's full portfolio →
UG UBS Group AG	16.8K	0.42%	−18.8K (−52.8%)	2023	0.0%
Shares held by quarter Peak holding616.3K (Q2'25) Change over 8 quarters+15.3K Share of the company0.420% UBS Group AG's full portfolio →

Geode Capital Management, LLC

20.2K

% of company

0.50%

Change vs last qtr

−28.1K (−58.2%)

Held since

Q1 '26

UBS Group AG

16.8K

% of company

0.42%

Change vs last qtr

−18.8K (−52.8%)

Held since

2023

11 more super investors behind a free account

See every manager holding Dermata Therapeutics Inc, how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting DRMA on Form N-PORT; together they hold 0.5% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
FE Fidelity Extended Market Index Fund Fidelity Concord Street Trust	$24.5K	19.0K	0.47%	0.00%	August 31, 2026
FS Fidelity Series Total Market Index Fund Fidelity Concord Street Trust	$1.43K	1.1K	0.03%	0.00%	August 31, 2026

Fidelity Extended Market Index Fund

Fidelity Concord Street Trust

Position value

$24.5K

% of company

0.47%

% of the fund

0.00%

As of

August 31, 2026

Fidelity Series Total Market Index Fund

Fidelity Concord Street Trust

Position value

$1.43K

% of company

0.03%

% of the fund

0.00%

As of

August 31, 2026

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
PG Proehl Gerald T 5%+ holder 13D · 17.3%	694.7K	17.27%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company17.270% Disclosed stake13D · 17.3% View the 13D/G filing →
KK Kyri K. Van Hoose 5%+ holder 13D · 9.0%	384.4K	9.56%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company9.560% Disclosed stake13D · 9.0% View the 13D/G filing →

Proehl Gerald T

5%+ holder13D · 17.3%

694.7K

% of company

17.27%

Change vs last qtr

—

Held since

—

Kyri K. Van Hoose

5%+ holder13D · 9.0%

384.4K

% of company

9.56%

Change vs last qtr

—

Held since

—

4 more holders behind a free account

See every insider and 5%+ holder of Dermata Therapeutics Inc.

Comments